UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma

Journal of cancer research and clinical oncology, 2021-03, Vol.147 (3), p.901-909

2021

Volltextzugriff (PDF)

Cerebrospinal fluid leakage repair of various grades developing during endoscopic transnasal transsphenoidal surgery

PloS one, 2021-03, Vol.16 (3), p.e0248229-e0248229

2021

Volltextzugriff (PDF)

The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells

Cancer letters, 2015-05, Vol.360 (2), p.195-204

2015

Volltextzugriff (PDF)

Changes in the Sphenoid Bone Encountered During the Endoscopic Endonasal Transsphenoidal Approach

The Laryngoscope, 2022-05, Vol.132 (5), p.965-972

2022

Volltextzugriff (PDF)

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Journal of neuro-oncology, 2020-02, Vol.146 (3), p.399-406

2020

Volltextzugriff (PDF)

Impact of Body Mass Index on Survival Outcome in Patients with Newly Diagnosed Glioblastoma: A Retrospective Single-Center Study

Integrative cancer therapies, 2021, Vol.20, p.1534735421991233-1534735421991233

2021

Volltextzugriff (PDF)

Intranasal Volume Changes Caused by the Endoscopic Endonasal Transsphenoidal Approach and Their Effects on Nasal Functions

PloS one, 2016-03, Vol.11 (3), p.e0151531-e0151531

2016

Volltextzugriff (PDF)

Metachronous double primary neuroendocrine tumors in larynx and lung: a case report

Journal of international medical research, 2020-11, Vol.48 (11), p.300060520962928-300060520962928

2020

Volltextzugriff (PDF)

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study

Cancer medicine (Malden, MA), 2022-01, Vol.11 (2), p.371-379

2022

Volltextzugriff (PDF)

Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)

Discover. Oncology, 2023-06, Vol.14 (1), p.90-90, Article 90

2023

Volltextzugriff (PDF)

Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas

Journal of neuro-oncology, 2013-12, Vol.115 (3), p.333-341

2013

Volltextzugriff (PDF)

Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma

International journal of clinical oncology, 2019-06, Vol.24 (6), p.666-676

2019

Volltextzugriff (PDF)

High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience

Asia-Pacific journal of clinical oncology, 2021-02, Vol.17 (1), p.123-130

2021

Volltextzugriff (PDF)

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy

Journal of Immunology Research, 2014-01, Vol.2014 (2014), p.1-16

2014

Volltextzugriff (PDF)

Invagination of the Sphenoid Sinus Mucosa after Endoscopic Endonasal Transsphenoidal Approach and Its Significance

PloS one, 2016-09, Vol.11 (9), p.e0162836-e0162836

2016

Volltextzugriff (PDF)

Anatomic Changes Caused by Endoscopic Endonasal Transsphenoidal Surgery and Their Effects on Nasal Functions

Otolaryngology-head and neck surgery, 2016-06, Vol.154 (6), p.1132-1137

2016

Volltextzugriff (PDF)

Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study

Journal of neuro-oncology, 2018-07, Vol.138 (3), p.667-677

2018

Volltextzugriff (PDF)

Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study

Journal of neuro-oncology, 2018-11, Vol.140 (2), p.445-455

2018

Volltextzugriff (PDF)

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2014-09, Vol.15 (10), p.1100-1108

2014

Volltextzugriff (PDF)

Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model

Clinical and Vaccine Immunology, 2010-01, Vol.17 (1), p.143-153

2010

Volltextzugriff (PDF)

Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma

Stem cells international, 2016-01, Vol.2016 (2016), p.1-7

2016

Volltextzugriff (PDF)

Significance of Measuring Lumbar Spine 3-Dimensional Computed Tomography Hounsfield Units to Predict Screw Loosening

World neurosurgery, 2022-09, Vol.165, p.e555-e562

2022

Volltextzugriff (PDF)

Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults

Neuro-oncology (Charlottesville, Va.), 2023-07, Vol.25 (7), p.1200-1224

2023

Volltextzugriff (PDF)

Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma

Immunology, 2007-12, Vol.122 (4), p.615-622

2007

Volltextzugriff (PDF)

Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type

The Korean Journal of Internal Medicine, 2018, 33(1), , pp.224-227

2018

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(233)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma

Cerebrospinal fluid leakage repair of various grades developing during endoscopic transnasal transsphenoidal surgery

The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells

Changes in the Sphenoid Bone Encountered During the Endoscopic Endonasal Transsphenoidal Approach

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Impact of Body Mass Index on Survival Outcome in Patients with Newly Diagnosed Glioblastoma: A Retrospective Single-Center Study

Intranasal Volume Changes Caused by the Endoscopic Endonasal Transsphenoidal Approach and Their Effects on Nasal Functions

Metachronous double primary neuroendocrine tumors in larynx and lung: a case report

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study

Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)

Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas

Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma

High‐dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15‐year multicenter experience

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy

Invagination of the Sphenoid Sinus Mucosa after Endoscopic Endonasal Transsphenoidal Approach and Its Significance

Anatomic Changes Caused by Endoscopic Endonasal Transsphenoidal Surgery and Their Effects on Nasal Functions

Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study

Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model

Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma

Significance of Measuring Lumbar Spine 3-Dimensional Computed Tomography Hounsfield Units to Predict Screw Loosening

Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults

Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma

Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type

Suchergebnisse filtern